Market Highlights
The
Poultry Vaccines Market plays a pivotal role in the broader scope of poultry
health management, serving as a cornerstone in disease prevention and overall
flock wellbeing. Poultry health
management encompasses a range of strategies aimed at safeguarding the
health of poultry populations, from biosecurity measures to vaccination
protocols. Within this framework, poultry vaccines serve as indispensable
tools, offering targeted protection against various pathogens that threaten
flock health. These vaccines are meticulously developed to address specific
disease challenges prevalent in poultry farming, including but not limited to
Newcastle disease, infectious bronchitis, and avian influenza. By incorporating
vaccines into comprehensive health management programs, poultry producers can
effectively mitigate disease risks, reduce mortality rates, and enhance overall
productivity, thereby ensuring the sustainability of their operations.
The Poultry
Vaccines Market Size was worth USD 1.8 billion in 2022 and is expected to
reach USD 3.32 billion by 2032 at 7.05% CAGR during the forecast period 2023 to
2032.The growth of the Poultry Vaccines Market is intricately linked to
advancements in poultry health management practices, driven by an increasing
emphasis on preventive healthcare in the poultry industry. As stakeholders
recognize the significance of proactive disease control measures, the demand
for innovative vaccines tailored to address emerging disease threats continues
to rise. Additionally, regulatory frameworks mandating the use of certain
vaccines to maintain flock health further propel market expansion. Moreover,
the adoption of advanced vaccination technologies, such as vector vaccines and
recombinant vaccines, underscores a paradigm shift towards more efficacious and
targeted disease management strategies. Overall, the Poultry Vaccines Market
stands as a critical component of poultry health management, offering
indispensable solutions to safeguard the welfare and productivity of poultry
populations in an ever-evolving agricultural landscape.
Key Players
Some
of the key Poultry Vaccines
Companies are
Boehringer
Ingelheim,
Elanco,
MSD
& Co.,
Zoetis
Inc,
Ceva
Animal Health Inc.,
Phibro
Animal Health Corporation,
Virbac,
Hipra,
Venkys,
Biovet,
and
Anicon
GmbH, and
Others.
Segmentation
The
global Poultry Vaccines
Market Report has been segmented based on diseases, technology, dosage form and
region.
- Based on disease, the market
has been classified as infectious bronchitis, avian influenza, marek's
disease, newcastle disease, and others. the market, by technology, has
been segmented into toxoid vaccines, recombinant
vaccines, inactivated vaccines, live attenuated vaccines (lav), and
others. based on dosage form, the market has been segmented into duct
vaccines, liquid vaccines, and freeze-dried vaccines.
- Based on technology, live
attenuated vaccines segment is expected to hold the largest market share
of the poultry vaccines market during the forecast period. Also,
recombinant vaccines segment to register the fastest growth in the global
poultry vaccines market during the forecast period.
Regional Analysis
The
Poultry Vaccines Market Outlook is likely to dominate by Americas during the
forecast period owing to the awareness about the prevention of animal-to-human
transmission diseases, rising demand for safe animal food supply, and
increasing investment in research and development for animal vaccines.
Moreover, high expenditure spending and favorable reimbursement policy also
fueling the growth of the market during forecast periods. The European market
is expected to be the second-largest due to government support for research
& development and improved animal husbandry practices. However, the market
in Asia-Pacific is anticipated to be the fastest-growing during the forecast
period owing to rising awareness and increase in the number of animal welfare
programs. The market in the Middle East & Africa is likely to account for
the smallest share of the global poultry vaccines market.
Related reports-
Amyotrophic
Lateral Sclerosis Market
For more information, Please Visit us @Market
Research Future
No comments:
Post a Comment